vs
Side-by-side financial comparison of EDGEWELL PERSONAL CARE Co (EPC) and Waldencast plc (WALD). Click either name above to swap in a different company.
EDGEWELL PERSONAL CARE Co is the larger business by last-quarter revenue ($422.8M vs $108.8M, roughly 3.9× Waldencast plc). EDGEWELL PERSONAL CARE Co runs the higher net margin — -15.5% vs -55.7%, a 40.1% gap on every dollar of revenue. On growth, Waldencast plc posted the faster year-over-year revenue change (17.8% vs -11.6%). Waldencast plc produced more free cash flow last quarter ($-13.9M vs $-137.5M).
The Edgewell Personal Care Company is an American multinational consumer products company headquartered in Shelton, Connecticut. It was formed in 2015 following the corporate spin-off from Energizer Holdings, Inc..
Waldencast plc is a global multi-brand platform focused on acquiring, developing and scaling high-growth premium niche brands across the beauty, personal care and wellness sectors. It operates primarily across North America and European markets, with core offerings including clean skincare, haircare, color cosmetics and wellness products targeted at quality-focused consumers.
EPC vs WALD — Head-to-Head
Income Statement — Q1 2026 vs Q4 2023
| Metric | | |
|---|---|---|
| Revenue | $422.8M | $108.8M |
| Net Profit | $-65.7M | $-60.6M |
| Gross Margin | 38.1% | 67.5% |
| Operating Margin | -4.5% | -42.9% |
| Net Margin | -15.5% | -55.7% |
| Revenue YoY | -11.6% | 17.8% |
| Net Profit YoY | -3028.6% | — |
| EPS (diluted) | $-1.41 | $-0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $422.8M | — | ||
| Q3 25 | $600.5M | — | ||
| Q2 25 | $627.2M | — | ||
| Q1 25 | $580.7M | — | ||
| Q4 24 | $415.1M | — | ||
| Q3 24 | $517.6M | — | ||
| Q2 24 | $647.8M | — | ||
| Q1 24 | $599.4M | — |
| Q4 25 | $-65.7M | — | ||
| Q3 25 | $-30.6M | — | ||
| Q2 25 | $29.1M | — | ||
| Q1 25 | $29.0M | — | ||
| Q4 24 | $-2.1M | — | ||
| Q3 24 | $8.8M | — | ||
| Q2 24 | $49.0M | — | ||
| Q1 24 | $36.0M | — |
| Q4 25 | 38.1% | — | ||
| Q3 25 | 37.9% | — | ||
| Q2 25 | 42.8% | — | ||
| Q1 25 | 44.1% | — | ||
| Q4 24 | 41.6% | — | ||
| Q3 24 | 41.1% | — | ||
| Q2 24 | 44.3% | — | ||
| Q1 24 | 43.1% | — |
| Q4 25 | -4.5% | — | ||
| Q3 25 | -4.2% | — | ||
| Q2 25 | 8.6% | — | ||
| Q1 25 | 10.1% | — | ||
| Q4 24 | 2.2% | — | ||
| Q3 24 | 3.9% | — | ||
| Q2 24 | 12.8% | — | ||
| Q1 24 | 11.7% | — |
| Q4 25 | -15.5% | — | ||
| Q3 25 | -5.1% | — | ||
| Q2 25 | 4.6% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | -0.5% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 7.6% | — | ||
| Q1 24 | 6.0% | — |
| Q4 25 | $-1.41 | — | ||
| Q3 25 | $-0.65 | — | ||
| Q2 25 | $0.62 | — | ||
| Q1 25 | $0.60 | — | ||
| Q4 24 | $-0.04 | — | ||
| Q3 24 | $0.18 | — | ||
| Q2 24 | $0.98 | — | ||
| Q1 24 | $0.72 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $21.1M |
| Total DebtLower is stronger | $1.5B | — |
| Stockholders' EquityBook value | $1.5B | $624.6M |
| Total Assets | $3.8B | $1.0B |
| Debt / EquityLower = less leverage | 1.03× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $209.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.6B | — |
| Q4 25 | $3.8B | — | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $3.8B | — | ||
| Q1 25 | $3.8B | — | ||
| Q4 24 | $3.7B | — | ||
| Q3 24 | $3.7B | — | ||
| Q2 24 | $3.7B | — | ||
| Q1 24 | $3.8B | — |
| Q4 25 | 1.03× | — | ||
| Q3 25 | 0.89× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 0.81× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.88× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-125.9M | $-13.4M |
| Free Cash FlowOCF − Capex | $-137.5M | $-13.9M |
| FCF MarginFCF / Revenue | -32.5% | -12.7% |
| Capex IntensityCapex / Revenue | 2.7% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $36.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-125.9M | — | ||
| Q3 25 | $74.1M | — | ||
| Q2 25 | $114.8M | — | ||
| Q1 25 | $45.1M | — | ||
| Q4 24 | $-115.6M | — | ||
| Q3 24 | $-388.3M | — | ||
| Q2 24 | $101.2M | — | ||
| Q1 24 | $129.0M | — |
| Q4 25 | $-137.5M | — | ||
| Q3 25 | $46.5M | — | ||
| Q2 25 | $99.3M | — | ||
| Q1 25 | $28.0M | — | ||
| Q4 24 | $-132.4M | — | ||
| Q3 24 | $-414.2M | — | ||
| Q2 24 | $88.6M | — | ||
| Q1 24 | $117.5M | — |
| Q4 25 | -32.5% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | -31.9% | — | ||
| Q3 24 | -80.0% | — | ||
| Q2 24 | 13.7% | — | ||
| Q1 24 | 19.6% | — |
| Q4 25 | 2.7% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 5.0% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 1.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.95× | — | ||
| Q1 25 | 1.56× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -44.13× | — | ||
| Q2 24 | 2.07× | — | ||
| Q1 24 | 3.58× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPC
| Other | $242.0M | 57% |
| Sunand Skin Care Segment | $131.5M | 31% |
| Shavinggelsandcreams | $32.3M | 8% |
| Wipes And Other Skin Care Products | $17.0M | 4% |
WALD
Segment breakdown not available.
